Teva (TEVA) in talks to buy Barr Pharmaceuticals Inc. (BRL) for about $7 billion - WSJ
More News related to BRL
- Mylan (MYL) Subsidiary Announces Favorable Court Ruling Against Barr Labs (BRL)
- Barr Labs (BRL) Receives Final FDA Approval for Generic Version of Razadyne(R) Tablets
- Barr Receives Approval for Generic Version of Razadyne(R) Tablets
- Barr Announces Favorable Ruling in Razadyne(R) Patent Challenge
- Barr Confirms Patent Challenge of FazaClo(R) Orally Disintegrating Tablets, 25mg and 100mg
More News related to TEVA
- Teva Pharmaceutical (TEVA) Reports ADAGIO Met Primary Endpoints in Phase III Trials
- ADAGIO Trial Results Show Teva's AZILECT(R) 1 mg Tablets Slow Progression of Parkinson's Disease
- CEL-SCI (CVM) In Licensing Agreement With Teva
- Gates' The Bill and Melinda Gates Foundation Shows New Positions in Crocs (CROX), Dick's (DKS) and Raised Stakes in McDonald's (MCD), FedEx (FDX) and AIG (AIG)
- Barr Pharmaceuticals (BRL) Reports Q2 Results; Guides
More News related to Mergers and Acquisitions
- LTX (LTXX) and Credence (CMOS) Complete Merger to Form LTX-Credence; Will Trade Under "LTXC"
- Gilat Satellite Networks (GILT) Terminates Merger Agreement with Consortium of Buyers; Will Receive $47.3M Termination Fee
- Gilat Satellite (GILT) Terminates Acquisition Agreement with Private Equity Consortium
- International Rectifier (IRF) Rejects Offer From Vishay Intertechnology (VSH)
- The PMI Group (PMI) Agrees to Sell Asia Operations for $56M
Teva (Nasdaq: TEVA) in talks to buy Barr Pharmaceuticals Inc. (NYSE: BRL) for about $7 billion - WSJ
Note: This was orignial reported by The Globes last night.
Related Categories
Mergers and AcquisitionsRumors
Stocks Mentioned
-0.31Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
